- Home
- SFM vs BMRN Comparison
SFM vs BMRN Comparison
Compare SFM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFM
- BMRN
- Stock Information
- Founded
- SFM 2002
- BMRN 1996
- Country
- SFM United States
- BMRN United States
- Employees
- SFM N/A
- BMRN N/A
- Industry
- SFM Food Chains
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SFM Consumer Staples
- BMRN Health Care
- Exchange
- SFM Nasdaq
- BMRN Nasdaq
- Market Cap
- SFM 10.9B
- BMRN 10.0B
- IPO Year
- SFM 2013
- BMRN 1999
- Fundamental
- Price
- SFM $110.49
- BMRN $53.41
- Analyst Decision
- SFM Buy
- BMRN Buy
- Analyst Count
- SFM 14
- BMRN 18
- Target Price
- SFM $170.36
- BMRN $93.71
- AVG Volume (30 Days)
- SFM 2.6M
- BMRN 2.1M
- Earning Date
- SFM 10-29-2025
- BMRN 10-24-2025
- Dividend Yield
- SFM N/A
- BMRN N/A
- EPS Growth
- SFM 52.36
- BMRN 154.69
- EPS
- SFM 4.84
- BMRN 3.40
- Revenue
- SFM $8,399,001,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- SFM $16.55
- BMRN $13.35
- Revenue Next Year
- SFM $11.38
- BMRN $9.18
- P/E Ratio
- SFM $23.12
- BMRN $15.68
- Revenue Growth
- SFM 16.83
- BMRN 18.36
- 52 Week Low
- SFM $98.75
- BMRN $51.57
- 52 Week High
- SFM $182.00
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- SFM 41.98
- BMRN 44.69
- Support Level
- SFM $109.44
- BMRN $51.57
- Resistance Level
- SFM $114.34
- BMRN $53.94
- Average True Range (ATR)
- SFM 3.58
- BMRN 1.35
- MACD
- SFM 2.06
- BMRN 0.01
- Stochastic Oscillator
- SFM 76.40
- BMRN 38.66
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.